CASSINOTTI, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 5.924
NA - Nord America 3.815
AS - Asia 3.057
SA - Sud America 266
AF - Africa 50
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.133
Nazione #
US - Stati Uniti d'America 3.704
GB - Regno Unito 2.713
CN - Cina 1.141
SG - Singapore 884
DE - Germania 837
IT - Italia 694
SE - Svezia 456
RU - Federazione Russa 280
HK - Hong Kong 276
UA - Ucraina 224
TR - Turchia 196
IN - India 181
BR - Brasile 164
NL - Olanda 139
FR - Francia 131
KR - Corea 129
IE - Irlanda 121
FI - Finlandia 112
EU - Europa 95
CA - Canada 83
PL - Polonia 68
VN - Vietnam 64
CO - Colombia 60
DK - Danimarca 41
JP - Giappone 38
ID - Indonesia 35
ES - Italia 20
BE - Belgio 19
AR - Argentina 18
CI - Costa d'Avorio 17
IQ - Iraq 16
UZ - Uzbekistan 15
BD - Bangladesh 12
MX - Messico 12
HU - Ungheria 11
IR - Iran 11
AU - Australia 9
ZA - Sudafrica 9
AE - Emirati Arabi Uniti 8
JO - Giordania 8
CH - Svizzera 7
EC - Ecuador 7
GR - Grecia 7
MA - Marocco 7
PK - Pakistan 6
UY - Uruguay 5
LB - Libano 4
NZ - Nuova Zelanda 4
PH - Filippine 4
PT - Portogallo 4
RO - Romania 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
AT - Austria 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
LU - Lussemburgo 3
LV - Lettonia 3
MY - Malesia 3
NO - Norvegia 3
PY - Paraguay 3
TW - Taiwan 3
VE - Venezuela 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
EG - Egitto 2
HN - Honduras 2
HT - Haiti 2
IM - Isola di Man 2
KH - Cambogia 2
KZ - Kazakistan 2
MD - Moldavia 2
PE - Perù 2
TN - Tunisia 2
YT - Mayotte 2
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BJ - Benin 1
BM - Bermuda 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CU - Cuba 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
IL - Israele 1
IS - Islanda 1
Totale 13.210
Città #
Southend 2.588
Singapore 467
Chandler 436
Ashburn 412
Frankfurt am Main 371
Beijing 268
Hong Kong 265
Jacksonville 203
Seattle 181
Wilmington 151
Princeton 150
Milan 142
Dublin 118
Dallas 110
Redmond 106
Bengaluru 97
Woodbridge 95
Somerville 88
Ann Arbor 85
Nanjing 82
Council Bluffs 81
Mountain View 81
Santa Clara 80
Los Angeles 79
Boardman 77
Fairfield 75
Serra 71
Munich 66
Dearborn 64
San Jose 64
Andover 63
Houston 61
Sakarya 61
Bogotá 60
Des Moines 58
Toronto 57
Warsaw 51
New York 43
Shanghai 43
Guangzhou 42
Buffalo 38
Phoenix 35
Nanchang 33
Cambridge 32
Changsha 32
Jinan 32
Helsinki 30
Fuzhou 28
Moscow 28
Shenyang 28
Sunnyvale 27
Tokyo 26
Berlin 25
Redwood City 23
Grafing 22
Hefei 22
Turin 22
Cangzhou 20
Rome 20
Zhengzhou 20
Tianjin 19
Abidjan 17
Turku 17
Bitonto 16
Fremont 16
Hangzhou 16
Brussels 15
Columbus 15
San Diego 15
Hanover 14
Jakarta 14
São Paulo 14
The Dalles 14
Trento 14
Padova 13
Wuhan 13
Hebei 12
Ho Chi Minh City 12
Jiaxing 12
Kiez 12
Quanzhou 12
Florence 11
London 11
Ningbo 11
Hanoi 10
Bühl 9
Lauterbourg 9
Ahmadabad 8
Boston 8
Castellanza 8
Dong Ket 8
Falls Church 8
Kunming 8
Lanzhou 8
Ottawa 8
Arese 7
Bari 7
Chicago 7
Düsseldorf 7
Eitensheim 7
Totale 8.697
Nome #
ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior 599
La leucocitoaferesi nel trattamento della colite ulcerosa 334
Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease 287
Autologous haematopoietic stem cell transplantation for Crohn's disease : a retrospective survey of long-term outcomes from the European Society for Blood and Marrow Transplantation 256
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up without CD34+ cell selection 254
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up with unselected stem cells 254
Isolated ampullary adenoma causing biliary obstruction 248
Serum protein profiling of early and advanced stage Crohn's disease 231
Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on Th1/Th2 cytokines in inflammatory bowel disease : an in vitro study 225
Prevalence, detection rate and outcome of Cytomegalovirus infection in ulcerative colitis patient requiring colonic resection 224
The PROSit cohort of infliximab biosimilar in IBD : a prolonged follow-up on the effectiveness and safety across Italy 220
CARD15 gene variants and risk of reoperation in Crohn's disease patients 220
Appropriateness and diagnostic yield of colonoscopy in the management of patients with ulcerative colitis : a prospective study in an open access endoscopy service 217
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alfa treatment 213
Use of colonoscopy in the management of patients with Crohn's disease: appropriateness and diagnostic yield 213
An evolutionary analysis of RAC2 identifies haplotypes associated with human autoimmune diseases 212
Autologous haematopoietic unselected peripheral blood stem cell transplantation in refractory Crohn's disease: up to 2-years follow-up of a phase I-II trial 211
Terapia medica della colite ulcerosa refrattaria 210
Clinical and endoscopic outcome after the first corticosteroid course in newly diagnosed ulcerative colitis : a 5-years follow-up inception cohort study 200
Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease 198
Autologous stem cell transplantation in moderate-severe refractory Crohn’s disease : the Milan experience without CD34+ cells selection 196
Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal 196
Prevalence and clinical significance of sonographic detection of enlarged regional lymph nodes in Crohn's disease 195
Autologous haematopoietic stem cell transplantation for refractory Crohn’s disease: updating the Milan experience without CD34+ cell selection 195
Autologous stem cell transplantation in Crohn's disease 194
Prevalence and clinical significance of sonographic alteration of mesenteric fat in Crohn's disease 194
Assessment of Crohn's disease activity by computed tomography enterography in patients with and without stenosis : a correlation with biochemical indexes of activity 193
Maintenance treatment with azathioprine in ulcerative colitis : outcomes after drug withdrawal in patients with sustained remission 192
Extraintestinal manifestations of inflammatory bowel disease 191
Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease 191
Clinical and endoscopic outcome after the first corticosteroid course in newly diagnosed ulcerative colitis : a 5-years follow-up inception cohort study 191
Vitamin D and inflammatory bowel disease 190
Role of dynamic transperineal ultrasound in obstructed defecation 187
Use of intestinal ultrasound combined with E-flow in the assessment of intestinal Crohn's disease (CD)complications : a preliminary report 185
Colonoscopy surveillance for dysplasia and colorectal cancer in long-standing ulcerative colitis: a cohort Italian study 183
Free IL-18 in Crohn's disease : is the target suitable for a therapeutic intervention with IL-18 binding protein? Validation of the expression of free IL-18 in sera of active patients 182
HLA and autoimmune digestive diseases : a clinically oriented review for gastroenterologists 181
Risk of clinical and surgical relapse in CD patients treated with azathioprine or mesalazine after conservative surgery, according to postoperative CRP levels 180
Colonoscopic surveillance for dysplasia and colorectal cancer in long-standing ulcerative colitis : a cohort Italian study 178
Autologous stem cell transplantation in moderate-severe refractory Crohn’s disease : the Milan experience without CD 34+ cells selection 175
Immunomodulatory effects of autologous stem cell transplantation in refractory Cronh’s disease : updatring the Milan experience without CD34+ cell selection 175
Autologous stem cell transplantation in moderate-severe refractory Crohn's disease : the Milan experience without CD34+ cells selection 174
Role, efficacy and safety of budesonide multi-matrix in ulcerative colitis in real life: A study in three Italian third-level centres 174
Maintenance treatment with azathioprine in ulcerative colitis : outcomes after drug withdrawal in patients with sustained remission 173
Modified Kudo classification can improve accuracy of virtual chromoendoscopy with FICE in endoscopic surveillance of ulcerative colitis 170
Comparison of beclomethasone dipropionate and mesalazine enemas versus each component alone in the treatment of distal ulcerative colitis 166
Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis : a real-life experience 166
New onset of atrial fibrillation after introduction of azathioprine in ulcerative colitis: case report and review of the literature 163
Crohn, morbo di 162
Sono gli immunosoppressori convenzionali i farmaci di prima scelta nel trattamento delle malattie infiammatorie croniche intestinali? 162
Prevalence and clinical significance of sonographic alteration of mesenteric fat in Crohn's disease 162
Bowel preparation in patients with inflammatory bowel disease 162
Clinical and endoscopic outcome after the first corticosteroid course in newly diagnosed ulcerative colitis : mucosal healing as prognostic predictor in a 5-years follow-up inception cohort study 160
Il trapianto autologo di cellule staminali ematopoietiche nel trattamento della malattia di Crohn : risultati preliminari e prospettive future 158
Prevalence and clinical significance of sonographic evidence of mesenteric fat alterations in Crohn's disease 157
Splanchnic haemodynamics and intestinal vascularity in ileal crohn's disease : an in vivo evaluation using doppler ultrasound, contrast-enhanced ultrasound and biochemical parameters 156
Imaging of perianal Crohn's disease 153
Adalimumab for the treatment of Crohn's disease 152
Colite ulcerosa 148
Use of double-balloon enteroscopy in the management of patients with Crohn's disease: feasibility and diagnostic yield in a high-volume centre for inflammatory bowel disease 142
Mycobacterium paratuberculosis e morbo di Crohn: Nuovi riscontri per un ruolo ritrovato 141
Role, efficacy and safety of budesonide-MMX in ulcerative colitis in real life : a study in a third-level center 139
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar 138
Prospettive in tema di terapia delle malattie infiammatorie croniche intestinali 131
La colite ulcerosa steroido-dipendente: quale terapia ? 129
Serum pro-hepcidin correlates with disease activity in inflammatory bowel disease patients 127
L'ABC delle malattie infiammatorie intestinali. Parte I: dalla patogenesi all'approccio clinico 127
NOD2/CARD15 gene mutations and risk of re-operation in Crohn's disease patients 125
Review article: the management of steroid dependency in ulcerative colitis 121
NOD2/CARD15 gene mutations and risk of re-operation in Crohn's disease patients 119
Infliximab improves erythropoiesis in Crohn's disease-associated anaemia 114
Smoker and ex-smoker patients affected by Crohn’s disease: are they so different? 113
Noninvasive Monitoring After Azathioprine Withdrawal in Patients With Inflammatory Bowel Disease in Deep Remission 92
Totale 13.646
Categoria #
all - tutte 32.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.276


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021953 0 0 0 0 0 0 161 56 200 140 270 126
2021/2022950 95 14 30 68 38 45 88 79 97 174 28 194
2022/20231.207 129 141 102 166 142 230 11 83 130 8 51 14
2023/2024833 16 52 24 44 174 78 70 76 31 55 88 125
2024/20251.689 97 141 58 238 132 40 32 162 91 138 153 407
2025/20261.918 429 210 304 235 354 238 148 0 0 0 0 0
Totale 13.646